Post by PressRelease on Aug 21, 2023 3:25pm
New Press Release - Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite
Comment by
juniper88 on Aug 21, 2023 3:54pm
Paul states at the end of the video that the new TH1902 trial protocol should be approved in the next 2 months. This is absurd.
Comment by
jfm1330 on Aug 21, 2023 4:04pm
What's that? The press release for results of Q2 inJuly started with this sentence: Sudocetaxel zendusortide Phase 1 Trial to resume following FDA agreement to amended protocol https://www.theratech.com/news-releases/news-release-details/theratechnologies-reports-second-quarter-2023-financial-results
Comment by
Trogarzon on Aug 21, 2023 4:09pm
They announced a PR for somthing recorded at Bloom Burton biotech conference at the end of febuary... it's a replay of old news to remind the market it's still news... something like that and akward at that.
Comment by
juniper88 on Aug 21, 2023 4:16pm
So the video was uploaded to YouTube 5 hours ago, and yes Paul states that the new protocol should be approved in the next couple of months. So, did the FDA approve the protocol or not? This is yet another of many unforced errors and just creates more confusion. Is this why the trial hasn't restarted, because the FDA didn't actually approve the new protocol yet?
Comment by
Trogarzon on Aug 21, 2023 4:18pm
This video dates back to febuary... the protocol was pproved in june....
Comment by
Mannequin on Aug 21, 2023 4:29pm
This is pathetic as Paul's comments must be wrong. Are we waiting 2 more months? What?? You say February. How would anyone know this? They are grasping at straws and we are worth 30% of 2 months ago.
Comment by
juniper88 on Aug 22, 2023 9:56am
"Paul Lvesque, President and Chief Executive Officer, Hamilton Thorne Ltd." Did Paul move to a new company?? Who is Hamilton Thorne Ltd.? What a mess.
Comment by
Trogarzon on Aug 22, 2023 9:59am
I want them OUT.... all of them OUT... BOD OUT.... Paul OUT... Dubuc OUT.... Out, Out, Out....
Comment by
Drmrgn on Aug 22, 2023 10:14am
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets. David Wolf is their CEO. Interesting though that they have $26M cash and looking for an acquisition and Thera market cap about $25M.
Comment by
Trogarzon on Aug 22, 2023 10:18am
Well they will need another 0 to buy me out.....
Comment by
Trogarzon on Aug 22, 2023 12:06pm
The CEO is like mentally inapt to run a public company. Hiding is not a strategy. For Christ f..g sake do something you m ron.
Comment by
Trogarzon on Aug 22, 2023 12:20pm
This thing has become a broken stock.. it's not even a company anymore... just a stupid price that keeps going down with nothing good to say about what they do and where they are heading... the dunpster.